Company / Working Capital
Design Therapeutics, Inc. Working Capital History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$210.7M
FY2025
5-year range
$210.7M / $380.2M
FY2021-FY2025
Trend
-12.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $380M to $211M over the past 4 years.
Based on SEC 10-K filings.
$211M in FY2025.
Declined from $380M to $211M over the past 4 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital decreased 12.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $210.7M | -12.0% |
| FY2024 | $239.6M | -37.0% |
| FY2021 | $380.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026